While the drugs have grown in popularity among doctors and patients, they are generally too expensive for most people to ...

Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for cardiometabolic diseases and GI oncological indications announced today that it ...

That's how much new U.S. tariffs could cost Mercedes-Benz this year, according to brokerage Bernstein—14% of expected operating profit. That is before any potential retaliation by U.S. trading ...

Novo Nordisk remains financially strong, but pricing pressures and CagriSema challenges limit near-term upside. Find out why ...

The secret of the president’s dramatic weight loss is the talk of the White House, our must-read newsletter The Swamp reveals.

Our writer shows how investing regularly in a SIPP account can lead to a £1m+ portfolio for savvy investors who start early ...

A few Easter eggs too many have stopped your weight-loss goals in their tracks, but don’t allow that to cause your motivation ...

Even those using appetite-suppressing jabs such as Ozempic and Wegovy need a similar mindset, Aherne says. Such drugs may have helped people to lose up to 20 per ... cost of up to pounds 300 a month ...

WEIGHT loss injections have become the holy grail in the fight against obesity, helping people shift the pounds they’ve been ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

Injectable medications originally developed for the treatment of diabetes are also effective for weight loss and have surged ...

But these drugs do expire after a few weeks, and microdosing could increase the risk of inadvertently using them after their ...